We are live on ! Find out more
FRLN

Freeline Therapeutics Holdings plc American Depositary Shares

Delisted

FRLN was delisted on the 16th of February, 2024.

19 hedge funds and large institutions have $144M invested in Freeline Therapeutics Holdings plc American Depositary Shares in 2021 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 6 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

5% less funds holding

Funds holding: 2019 (-1)

34% less capital invested

Capital invested by funds: $217M → $144M (-$72.6M)

67% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 6

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
19
Holders Change
-1
Holders Change %
-5%
% of All Funds
0.33%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
Increased
2
Reduced
6
Closed
1
Calls
Puts
Net Calls
Net Calls Change

FRLN Hedge Fund Activity: Q1 2021 in Review

19 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Freeline Therapeutics Holdings plc American Depositary Shares (FRLN) for Q1 2021, worth a combined $144M — down 34% from $217M a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of FRLN and 0 opened new positions — a net loss of 1 holder — while 6 trimmed existing stakes and 2 added.

The largest buyer was CHI Advisors, adding an estimated $374K. The largest seller was Wellington Management Group, cutting an estimated $2.13M.

  • 19 institutional investors held Freeline Therapeutics Holdings plc American Depositary Shares (FRLN) as of Q1 2021, down from 20 in Q4 2020.
  • Funds reported $144M of Freeline Therapeutics Holdings plc American Depositary Shares stock for Q1 2021, down 34% quarter-over-quarter.
  • 0 funds opened new Freeline Therapeutics Holdings plc American Depositary Shares positions in Q1 2021 and 1 closed out, a net change of -1 holder.
  • The largest Freeline Therapeutics Holdings plc American Depositary Shares buyer in Q1 2021 was CHI Advisors, an estimated $374K added.
  • The largest Freeline Therapeutics Holdings plc American Depositary Shares seller in Q1 2021 was Wellington Management Group, an estimated $2.13M sold.

Based on aggregated 13F filings for Q1 2021.